Shares of companies that are part of the growing effort to find an effective treatment for the deadly Ebola virus were sharply higher in premarket trade Monday, after a nurse who cared for the Ebola patient who died in Dallas last week tested positive for the disease. Among the gainers, penny stock Ibio surged 77% to $2.61, on reports it may become part of the government's effort to ramp up production of ZMapp. The experimental drug was developed by privately-held Mapp Biophamaceuticals and used to save the lives of two American health workers who were infected but recovered. Shares of Tekmira Pharmaceuticals Corp. , maker of the TKM-Ebola drug, rose 5.8%. Shares of Hazmat-suit maker Lakeland Industries rose 22.3%. Shares of Alpha Pro Tech , which makes face masks, climbed 17%.
Copyright © 2014 MarketWatch, Inc.
Continue Reading Below